Advertisement
Advertisement
LYEL
Lyell Immunopharma, Inc. Common Stock
10.53
USDSponsored
-0.62
-5.56%
Sep 23, 15:59 UTC -4
Closed
After-Market
10.54
+0.01
+0.09%
Lyell Immunopharma, Inc. Common Stock Financial Snapshot
| Market Cap | 258.28M |
| Beta | -0.04 |
| Earnings Per Share (EPS) | -12.83 |
| Price-to-Book (P/B) Ratio | 1.15 |
| Operating Margin | -920285.25% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -91.62% |
| Current Ratio | 5.36% |
| Free Cash Flow | -72.77M |
